PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathways

References

• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• WilliamsonSCHartleyAEHeerRA review of tasquinimod in the treatment of advanced prostate cancerDrug Des Devel Ther20137167174
   PubMed Web of Science ®Google Scholar
• AnsariJHussainSAZarkarATanguayJSBlissJGlaholmJDocetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experienceOncol Rep200820489189618813832
   PubMed Web of Science ®Google Scholar
• de BonoJSLogothetisCJMolinaAAbiraterone and increased survival in metastatic prostate cancerN Engl J Med2011364211995200521612468
   PubMed Web of Science ®Google Scholar
• Southwest Oncology GroupBerryDLMoinpourCMJiangCSQuality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisoneJ Clin Oncol200624182828283516782921
   PubMed Web of Science ®Google Scholar
• JohnstoneRWRuefliAALoweSWApoptosis: a link between cancer genetics and chemotherapyCell2002108215316411832206
   PubMed Web of Science ®Google Scholar
• LoweSWCeperoEEvanGIntrinsic tumour suppressionNature2004432701530731515549092
   PubMed Web of Science ®Google Scholar
• AdamsJMCorySThe Bcl-2 apoptotic switch in cancer development and therapyOncogene20072691324133717322918
   PubMed Web of Science ®Google Scholar
• CoutureFD’AnjouFDayROn the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applicationsBiomol Concepts20112542143822308173
   PubMedGoogle Scholar
• SeidahNGPratAThe biology and therapeutic targeting of the pro-protein convertasesNat Rev Drug Discov201211536738322679642
   PubMed Web of Science ®Google Scholar
• TsujiAHashimotoEIkomaTInactivation of proprotein convertase, PACE4, by alpha1-antitrypsin Portland (alpha1-PDX), a blocker of proteolytic activation of bone morphogenetic protein during embryogenesis: evidence that PACE4 is able to form an SDS-stable acyl intermediate with alpha1-PDXJ Biochem1999126359160310467177
   PubMed Web of Science ®Google Scholar
• YuasaKMasudaTYoshikawaCNagahamaMMatsudaYTsujiASubtilisin-like proprotein convertase PACE4 is required for skeletal muscle differentiationJ Biochem2009146340741519520771
   PubMed Web of Science ®Google Scholar
• TsujiASakuraiKKiyokageESecretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrixBiochim Biophys Acta2003164519510412535616
   PubMed Web of Science ®Google Scholar
• YanaIWeissSJRegulation of membrane type-1 matrix metalloproteinase activation by proprotein convertasesMol Biol Cell20001172387240110888676
   PubMed Web of Science ®Google Scholar
• DuboisCMBlanchetteFLapriseMHLeducRGrondinFSeidahNGEvidence that furin is an authentic transforming growth factor-beta1-converting enzymeAm J Pathol2001158130531611141505
   PubMed Web of Science ®Google Scholar
• SunGGLuYFZhangJHuWNFilamin A regulates MMP-9 expression and suppresses prostate cancer cell migration and invasionTumour Biol20143543819382624390612
   PubMedGoogle Scholar
• HubbardFCGoodrowTLLiuSCExpression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive abilityCancer Res19975723522652319393739
   PubMed Web of Science ®Google Scholar
• KangSZhaoYHuKmiR-124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathwayProstate201474111095110624913567
   PubMed Web of Science ®Google Scholar
• LonguespéeRCoutureFLevesqueCImplications of proprotein convertases in ovarian cancer cell proliferation and tumor progression: Insights for PACE4 as a therapeutic targetTransl Oncol Epub201459
   Web of Science ®Google Scholar
• D’AnjouFRouthierSPerreaultJPMolecular validation of PACE4 as a target in prostate cancerTransl Oncol20114315717221633671
   PubMed Web of Science ®Google Scholar
• KleeEWBondarOPGoodmansonMKCandidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and bloodClin Chem201258359960922247499
   PubMed Web of Science ®Google Scholar
• KueferRHoferMDAltugVSodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancerBr J Cancer200490253554114735205
   PubMed Web of Science ®Google Scholar
• EstiloCLO-charoenratPTalbotSOral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysisBMC Cancer200991119138406
   PubMed Web of Science ®Google Scholar
• KurokawaYMatobaRNakamoriSPCR-array gene expression profiling of hepatocellular carcinomaJ Exp Clin Cancer Res200423113514115149162
   PubMed Web of Science ®Google Scholar
• DelicSLottmannNJetschkeKReifenbergerGRiemenschneiderMJIdentification and functional validation of CDH11, PCSK6 and SH3GL3 as novel glioma invasion-associated candidate genesNeuropathol Appl Neurobiol201238220121221722156
   PubMed Web of Science ®Google Scholar
• MahloogiHBassiDEKlein-SzantoAJMalignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4Carcinogenesis200223456557211960907
   PubMed Web of Science ®Google Scholar
• TaitSWGreenDRMitochondria and cell death: outer membrane permeabilization and beyondNat Rev Mol Cell Biol201011962163220683470
   PubMed Web of Science ®Google Scholar
• LaCasseECMahoneyDJCheungHHPlenchetteSBairdSKornelukRGIAP-targeted therapies for cancerOncogene200827486252627518931692
   PubMed Web of Science ®Google Scholar
• SerranoMLSánchez-GómezMBravoMMYakarSLeRoithDDifferential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell linesHorm Metab Res2008401066166718711691
   PubMed Web of Science ®Google Scholar
• PetterssonFDalgleishAGBissonnetteRPColstonKWRetinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/BaxBr J Cancer200287555556112189556
   PubMed Web of Science ®Google Scholar
• DufeyESepúlvedaDRojas-RiveraDHetzCCellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 1. An overviewAm J Physiol Cell Physiol20143077C582C59425143348
   PubMed Web of Science ®Google Scholar
• DuanZZhaoJFanXThe PERK-eIF2α signaling pathway is involved in TCDD-induced ER stress in PC12 cellsNeurotoxicology20144414915924932542
   PubMed Web of Science ®Google Scholar
• CuiWYLiuYZhuYQSongTWangQSPropofol induces endoplasmic reticulum (ER) stress and apoptosis in lung cancer cell H460Tumour Biol20143565213521724510348
   PubMedGoogle Scholar
• LiuCYSchröderMKaufmanRJLigand-independent dimerization activates the stress response kinases IRE1 and PERK in the lumen of the endoplasmic reticulumJ Biol Chem200027532248812488510835430
   PubMed Web of Science ®Google Scholar
• SzegezdiELogueSEGormanAMSamaliAMediators of endoplasmic reticulum stress-induced apoptosisEMBO Rep20067988088516953201
   PubMed Web of Science ®Google Scholar
• NordinNMajidNAHashimNMRahmanMAHassanZAliHMLiriodenine, an aporphine alkaloid from Enicosanthellum pulchrum, inhibits proliferation of human ovarian cancer cells through induction of apoptosis via the mitochondrial signaling pathway and blocking cell cycle progressionDrug Des Devel Ther2015914371448
   PubMed Web of Science ®Google Scholar
• RodríguezLVillalobosXDakhelSPolypurine reverse Hoogsteen hairpins as a gene therapy tool against survivin in human prostate cancer PC3 cells in vitro and in vivoBiochem Pharmacol201386111541155424070653
   PubMed Web of Science ®Google Scholar
• SwiftSLRiveraGCDussuptVEvaluating baculovirus as a vector for human prostate cancer gene therapyPLoS One201386e6555723755250
   PubMed Web of Science ®Google Scholar
• KangSZhaoYHuKmiR-124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathwayProstate201474111095110624913567
   PubMed Web of Science ®Google Scholar
• YuasaKSuzueKNagahamaMMatsudaYTsujiATranscriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progressionGene20074021–210311017825503
   PubMed Web of Science ®Google Scholar
• LapierreMSiegfriedGScamuffaNOpposing function of the proprotein convertases furin and PACE4 on breast cancer cells’ malignant phenotypes: role of tissue inhibitors of metalloproteinase-1Cancer Res200767199030903417909005
   PubMed Web of Science ®Google Scholar
• LevesqueCCoutureFKwiatkowskaAPACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neo-vascularisationOncotarget2015663680369325682874
   PubMedGoogle Scholar